We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[BIOMARKER ST2 AS A NEW PREDICTOR OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION].
Georgian Medical News 2018 September
Aim - to research sST2 level in risk of acute kidney injury after ST-elevation myocardial infarction (STEMI). 103 patients with STEMI, 75 (72.8%) male and 28 (27.2%) female at average age 61.85±12.23 years were enrolled. All the patients were divided to 2 groups according to AKIN classification: with creatinine dynamic more than 26.4 µmol/l (1st and more stage) and without those. Serum level of sST2, N-terminated pro-B-type natriuretic peptide (NT- proBNP ) determined by enzyme-like immunoassay at the 1st day of STEMI. Serum median level of sST2 in the 1st and 2nd groups were 128.62 [13.05-381.4] ng/ml and 54.7 [16.4-262.2] ng/ml accordantly (р = 0.0004). Biomarkers were determined in the serum of STEMI patients on baseline prognosed acute kidney injury (AKI) across 48 hours. sST2 level increase more than 36.4 ng/ml and NT- proBNP more than 1345 pg/ml prognosed AKI in patients with STEMI. sST2 in addition to NT- proBNP might be used as a main instrument of risk stratification of AKI development in patients with STEMI.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app